ICL Israel Chemicals’ third-quarter earnings were higher than expected, while revenue was lower than expected.

© Natalie Kadosh, ICL Group PR ICL Israel Chemicals’ third-quarter earnings beat expectations, revenues fell short of expectations.

Investing.com – ICL Israel Chemicals (NYSE:) third-quarter report beats analysts’ estimates, with income below expected numbers, according to information released on Wednesday.

ICL Israel Chemicals’ earnings per share (EPS) were $0.110 on revenue of $1.86 billion, while the analyst consensus compiled by ICL Israel Chemicals was $0.110 on revenue of $1.86 billion. Investment.com was previously expected to forecast US$0.098 per share based on revenues of US$1.89 billion.

In addition to ICL Israel Chemicals, there are other companies. The Basic Materials Industry Group on the New York Stock Exchange markets announces its earnings this month

Previously, Sherwin-Williams reported third-quarter earnings of $3.2 per share on revenue of $6.12 billion, versus estimates of $2.78 on revenue of $6.02 billion.

Vale ADR’s recent reported performance has exceeded analyst expectations. Third-quarter earnings were $0.66 per share on revenue of $10.62 billion, beating analyst estimates for 2020. Investment.com EPS is expected to be approximately $0.6024 on revenue of $10.86 billion.

Follow the latest developments in the company’s earnings via the Investing.com earnings calendar

Leave a Reply

Your email address will not be published. Required fields are marked *